Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1486, 2005-01, pp. : 17-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Colesevelam add-on therapy cost effective in T2DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 613, 2010-01 ,pp. :
INNOVATEive omalizumab therapy effective in difficult-to-treat asthma
Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. :